Ken Kumagai

Dr. Ken Kumagai

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2018 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
AMAya Mizuguchi
Aya Mizuguchi
ATAtsushi Takai
Atsushi Takai
TSTakahiro Shimizu
Takahiro Shimizu
TMTomonori Matsumoto
Tomonori Matsumoto
KKKen Kumagai
Ken Kumagai
HMHiroyuki Marusawa
Hiroyuki Marusawa
Chronic gastritis caused by Helicobacter pylori (H. pylori) infection could lead to the development of gastric cancer. The finding that multiple gastric cancers can develop synchronously and/or metachronously suggests the development of field cancerization in chronically inflamed, H. pylori‐infected gastric mucosa. The genetic basis of multiple tumorigenesis in the inflamed stomach, however, is not well understood. In this study, we analyzed the microsatellite instability (MSI) status and copy number aberrations (CNAs) of 41 multiple intramucosal early gastric cancers that synchronously or metachronously developed in 19 patients with H. pylori infection. Among the 41 intramucosal gastric carcinomas, 9 (22%) exhibited MSI, and the remaining 32 (78%) exhibited the microsatellite stable (MSS) phenotype. Metachronous multiple intramucosal gastric carcinoma exhibit inter‐tumor heterogeneity by individually acquiring genetic aberrations. All synchronous multiple intramucosal gastric carcinoma pairs shared a common MSI/MSS profile, and CNA analysis revealed that synchronous multiple intramucosal gastric carcinoma pairs with the MSS phenotype shared common aberrations of representative tumor‐suppressor genes, including focal deletion of APC, TP53, CDKN2A, and CDKN2B. Multiregional CNA analysis revealed that heterogeneous gene amplifications/deletions, including PDL1 amplification, evolved under the presence of shared “trunk” genetic alterations in a subpopulation of individual intramucosal gastric carcinomas. These data suggest that multiple gastric carcinomas develop in a multicentric/multifocal manner exhibiting features of inter‐ and intra‐tumor heterogeneity in H. pylori‐infected gastric mucosa, whereas synchronous multiple intramucosal gastric carcinomas could share partially common genetic alterations, possibly via common oncogenic pathways.

26 January 2023 in The Journal of Pathology
Verified
Journal Article
Closed access
KKKen Kumagai
Ken Kumagai
TSTakahiro Shimizu
Takahiro Shimizu
MNMitsuhiro Nikaido
Mitsuhiro Nikaido
THTomonori Hirano
Tomonori Hirano
NKNobuyuki Kakiuchi
Nobuyuki Kakiuchi
HSHiroshi Seno
Hiroshi Seno

9 April 2021 in Pathogens
Verified
Journal Article
Open access
PDF file
RNRisa Nakanishi
Risa Nakanishi
TSTakahiro Shimizu
Takahiro Shimizu
KKKen Kumagai
Ken Kumagai
ATAtsushi Takai
Atsushi Takai
HMHiroyuki Marusawa
Hiroyuki Marusawa
Epidemiological, clinical, and biological studies convincingly demonstrate that chronic inflammation predisposes to the development of human cancers. In digestive organs, inflammation-associated cancers include colitis-associated colorectal cancers, Helicobacter pylori-associated gastric cancer, as well as Barrett’s esophagus and esophageal adenocarcinoma associated with chronic duodenogastric-esophageal reflux. Cancer is a genomic disease, and stepwise accumulation of genetic and epigenetic alterations of tumor-related genes leads to the development of tumor cells. Recent genome analyses show that genetic alterations, which are evoked by inflammation, are latently accumulated in inflamed epithelial cells of digestive organs. Production of reactive oxygen and aberrant expression of activation-induced cytidine deaminase, a nucleotide-editing enzyme, could be induced in inflamed gastrointestinal epithelial cells and play a role as a genomic modulator of inflammation-associated carcinogenesis. Understanding the molecular linkage between inflammation and genetic alterations will open up a new field of tumor biology and provide a novel strategy for the prevention of inflammation-associated tumorigenesis.


7 November 2025 in Surgical Endoscopy
Verified
Journal Article
Closed access
PDF file
TYTakaaki Yoshikawa
Takaaki Yoshikawa
TUTakahiro Utsumi
Takahiro Utsumi
TITakahiro Inoue
Takahiro Inoue
NANobukazu Agatsuma
Nobukazu Agatsuma
YTYukari Tanaka
Yukari Tanaka
KPKonoe Project
Konoe Project

16 January 2025 in DEN Open
Verified
Journal Article
Open access
KKKen Kumagai
Ken Kumagai
YTYutaka Takada
Yutaka Takada
ASAyaka Sugimoto
Ayaka Sugimoto
SSShinjiro Sakagami
Shinjiro Sakagami
YAYuri Akioka
Yuri Akioka
TIToshinao Itani
Toshinao Itani
The management of locally advanced esophageal cancer typically involves esophagectomy; however, postoperative complications, particularly anastomotic stricture, remain prevalent. Anastomotic stricture can severely compromise patients' quality of life by leading to difficulties in food intake. Although endoscopic balloon dilation has become a standard treatment for gastrointestinal strictures, its efficacy is often limited due to the risk of perforation and the potential for recurrent stricture, necessitating multiple interventions. Recent advancements have introduced endoscopic radial incision and cutting methods, which aim to enhance patency by excising scar tissue. We experienced a case resistant to the radial incision and cutting therapy, necessitating further intervention strategies. This report details our experience utilizing a novel technique, endoscopic incisional balloon dilation, which combines endoscopic incisional technique and balloon dilation therapy with anti‐scarring medications, in cases of refractory anastomotic strictures following esophageal cancer resection. We present three challenging cases in which endoscopic incisional balloon dilation yielded significant clinical improvements, alongside supportive literature. Our findings suggest that endoscopic incisional balloon dilation is an effective and safer alternative to conventional methods, capable of addressing complex stricture scenarios while potentially enhancing patient outcomes and quality of life.